C2C

 

Title: C2C: COMBINE-2 for Cabotegravir+Rilpivirine LA Regimen - A Prospective Cohort Study to Monitor Effectiveness, Adherence and Resistance

Sites: Ongoing 
Territories: UK, Belgium, France, Germany, Italy, Netherlands, Spain, Switzerland & Sweden
Status: Ongoing, open to recruitment

​

​